These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 19154499
1. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses. Zini L, Perrotte P, Jeldres C, Capitanio U, Duclos A, Jolivet-Tremblay M, Arjane P, Péloquin F, Pharand D, Villers A, Montorsi F, Patard JJ, Karakiewicz PI. BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499 [Abstract] [Full Text] [Related]
6. A non-cancer-related survival benefit is associated with partial nephrectomy. Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI. Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373 [Abstract] [Full Text] [Related]
7. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Zini L, Capitanio U, Perrotte P, Jeldres C, Shariat SF, Arjane P, Widmer H, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2009 Feb; 73(2):342-6. PubMed ID: 19041122 [Abstract] [Full Text] [Related]
8. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Lane BR, Abouassaly R, Gao T, Weight CJ, Hernandez AV, Larson BT, Kaouk JH, Gill IS, Campbell SC. Cancer; 2010 Jul 01; 116(13):3119-26. PubMed ID: 20564627 [Abstract] [Full Text] [Related]
9. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Cancer; 2007 May 01; 109(9):1763-8. PubMed ID: 17351954 [Abstract] [Full Text] [Related]
10. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma. Zini L, Patard JJ, Capitanio U, Crepel M, de La Taille A, Tostain J, Ficarra V, Bernhard JC, Ferrière JM, Pfister C, Villers A, Montorsi F, Karakiewicz PI. BJU Int; 2009 Apr 01; 103(7):894-8. PubMed ID: 19076131 [Abstract] [Full Text] [Related]
11. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC. J Urol; 2007 Aug 01; 178(2):429-34. PubMed ID: 17561141 [Abstract] [Full Text] [Related]
12. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML. J Urol; 2008 Feb 01; 179(2):468-71; discussion 472-3. PubMed ID: 18076931 [Abstract] [Full Text] [Related]
16. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2010 Feb 01; 75(2):271-5. PubMed ID: 19962740 [Abstract] [Full Text] [Related]
17. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Marszalek M, Meixl H, Polajnar M, Rauchenwald M, Jeschke K, Madersbacher S. Eur Urol; 2009 May 01; 55(5):1171-8. PubMed ID: 19232819 [Abstract] [Full Text] [Related]
18. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Piñeiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ. Eur Urol; 2010 Mar 01; 57(3):466-71. PubMed ID: 19359089 [Abstract] [Full Text] [Related]
19. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ. J Urol; 2008 May 01; 179(5):1719-26. PubMed ID: 18343437 [Abstract] [Full Text] [Related]
20. Rising incidence of small renal masses: a need to reassess treatment effect. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. J Natl Cancer Inst; 2006 Sep 20; 98(18):1331-4. PubMed ID: 16985252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]